-
-
Need to Know
![Here’s why investors should be hanging onto a battered Amazon right now]()
Here’s why investors should be hanging onto a battered Amazon right now
- Antitrust laws aren’t enough to break up Amazon, Facebook and Google, says Howard Gold
- ‘It’s war’: Trump reportedly seeking ways to hurt Amazon
- Trump’s attacks on Amazon break with history of presidents keeping hands off
- Amazon customers are fiercely loyal — and this is why Trump’s tweets won’t change that
-
Personal finance
![A second chance for student loan forgiveness]()
A second chance for student loan forgiveness
Student loan borrowers who missed out on loan forgiveness should move now for another shot at it.
![This city is setting the bar for being retiree-friendly]()
This city is setting the bar for being retiree-friendly
An insider’s tale of making Pittsburgh great for residents of all ages.
-
Inside MarketWatch
Snap in 'potentially promising position' after Facebook's Cambridge Analytica scandal, says analyst
Analyst James Cakmak of Monness, Crespi, Hardt & Co. wrote Tuesday that Snap Inc. might be in a relatively good position in the wake of Facebook Inc.'s Cambridge Analytica scandal, due to Snap's "relatively stricter privacy parameters." He argued that Snap doesn't collect data from direct messages sent on the platform and limits the data that third-party developers can access. "The targeting and measurement criticisms previously waged on the company given the limitations to data may end up serving as a blessing in disguise," Cakmak wrote. "It's our understanding Snap is not explicitly using Facebook's challenges as a source of negotiating leverage; however, the relative underinvestment on the platform from advertisers and agencies presents opportunities to close the gap." Cakmak has a hold rating on Snap shares, which are down 3.7% in Tuesday morning trading. Snap's stock is down 38% over the past 12 months, compared with a 10% gain for the S&P 500 in that time.
Walmart in talks to buy online pharmacy PillPack: report
Walmart Inc. is in talks to acquire online pharmacy startup PillPack, CNBC reported Monday night. The deal, which would be valued at less than $1 billion, is not yet finalized, CNBC said. Adding PillPack could make it easier for Walmart customers to order and manage prescriptions. The potential acquisition comes days after Walmart was reported to be in early talks to buy health insurer Humana Inc. in a deal valued around $37 billion, vastly expanding the retail giant's reach into health care. According to its website, Massachusetts-based PillPack has raised $118 million in funding.
GE's stock drops to pace Dow decliners after analyst cuts price target
Shares of General Electric Co. dropped 1.3% in morning trade Tuesday, enough to pace the Dow Jones Industrial Average's decliners, after Stifel Nicolaus cut its price target, citing continued challenges at its power business and overall growth concerns. The stock was trading just above the March 26 close of $12.89, which was the lowest close since July 29, 2009. Stifel analyst Robert McCarthy cut his price target to $13 from $15, while maintaining the hold rating he's had on the stock since Oct. 23, 2017. His price target is now the second lowest among the 19 analysts surveyed by FactSet. McCarthy expects slower overall growth across GE's long-cycle businesses and challenges from inflation of materials costs. He proposes management consider capping the pension benefits for high-level, long-tenured employees "to provide the appropriate 'virtue' signaling in GE's current cash priority environment." The stock has plunged 28.7% over the past three months, while the Dow has slipped 4.5%.
